[PDF][PDF] PERK EIF2AK3 control of pancreatic β cell differentiation and proliferation is required for postnatal glucose homeostasis

W Zhang, D Feng, Y Li, K Iida, B McGrath, DR Cavener - Cell metabolism, 2006 - cell.com
W Zhang, D Feng, Y Li, K Iida, B McGrath, DR Cavener
Cell metabolism, 2006cell.com
Summary Mutations in PERK (EIF2AK3) result in permanent neonatal diabetes as well as
several other anomalies that underlie the human Wolcott-Rallison syndrome, and these
anomalies are mirrored in Perk knockout mice. To identify the cause of diabetes in PERK-
deficient mice, we generated a series of tissue-and cell-specific knockouts of the Perk gene
and performed a developmental analysis of the progression to overt diabetes. We
discovered that PERK is specifically required in the insulin-secreting β cells during the fetal …
Summary
Mutations in PERK (EIF2AK3) result in permanent neonatal diabetes as well as several other anomalies that underlie the human Wolcott-Rallison syndrome, and these anomalies are mirrored in Perk knockout mice. To identify the cause of diabetes in PERK-deficient mice, we generated a series of tissue- and cell-specific knockouts of the Perk gene and performed a developmental analysis of the progression to overt diabetes. We discovered that PERK is specifically required in the insulin-secreting β cells during the fetal and early neonatal period as a prerequisite for postnatal glucose homeostasis. However, PERK expression in β cells is not required at the adult stage to maintain β cell functions and glucose homeostasis. We show that PERK-deficient mice exhibit severe defects in fetal/neonatal β cell proliferation and differentiation, resulting in low β cell mass, defects in proinsulin trafficking, and abrogation of insulin secretion that culminate in permanent neonatal diabetes.
cell.com